Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22714001 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of BMS-790052 Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin)
Condition: Hepatitis C
Interventions: Drug: BMS-790052;   Drug: Placebo;   Drug: Peginterferon alpha-2a;   Drug: ribavirin

Indicates status has not been verified in more than two years